CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,190 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06029777
NCT06029777N/ACompleted

Peri-luminal COROnary CTa AI-driven radiOMICS to Identify Vulnerable Patients

IRCCS San Raffaele·observational·Posted Sep 8, 2023·Updated Jan 15, 2026

In Brief

An observational study for Coronary Artery Disease. Completed, enrolled 2,190 participants across 1 site.

Detailed Summary

CAD is a leading cause of mortality in Europe. cCTA is recommended to rule out obstructive CAD, but, in most patients, it shows non-obstructive CAD. The management of these patients is unclear due to lack of reproducible quantitative measurement, beyond stenosis severity, capable to assess the risk of disease progression towards developing MACEs. To improve identification and phenotypization of patients at high risk of disease progression, the investigators propose the application of artificial intelligence algorithms to cCTA images to automatically extract periluminal radiomics features to characterize the atherosclerotic process. By leveraging machine-learning empowered radiomics the investigators aim to improve patients' risk stratification in a robust, quantitative and reproducible fashion. By developing a novel quantitative AI based cCTA measure, the investigators expect to provide a risk score capable to identify patients who can benefit of a more aggressive medical treatment and management, thus improving outcome

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly

Timeline

N/ACompletedFinished
202420252026
First PostedSep 8, 2023
Enrollment StartJul 31, 2023
Primary CompletionSep 24, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.8 years ago